InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Breber Sandra, 首席执行官. Officer active across 2 companies, notably Augmedix, Inc.. In total, 4 filings have been logged. Split: 1 buy · 0 sell. Total volume traded: €43k. Activity tracked since 28 October 2021. The latest transaction was disclosed on 2 October 2024 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Breber Sandra
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
20,295 股@ US$2.35100.0% 占其流量Common StockSEC:0001213900-24-085366:0
6,250 股Common StockSEC:0001213900-24-070867:0
6,250 股Common StockSEC:0001213900-24-044876:0
12,500 股@ US$4.00100.0% 占其流量Common StockSEC:0001213900-21-055926:0
标准退出：2022年1月26日 (T+90)
4 条申报中的 4 条
About Breber Sandra
Sandra Breber is the Chief Operating Officer at Augmedix, Inc. She is responsible for managing operations and implementing growth strategies. Her role is essential for ensuring the company's efficiency and profitability.
